Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

413

HTML

3230

Figures (1-3)

204

Tables (1-4)

173

Sum=4020

Apr 7, 2008 (publication date) through Aug 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Apr 7, 2008; 14(13): 2100-2105
Published online Apr 7, 2008. doi: 10.3748/wjg.14.2100

Table 1 Semi-quantitative scores of hepatic fibrosis staging

Score	Pathological description	Stage
0	No fibrosis	No fibrosis
1	Slight fibrosis	Periportal fibrosis
2	Medium fibrosis	Enlarged periportal fibrosis
3	Severe fibrosis	Bridging fibrosis
4	Cirrhosis	Cirrhosis

Citation: Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl₄-induced hepatic fibrosis. World J Gastroenterol 2008; 14(13): 2100-2105
URL: https://www.wjgnet.com/1007-9327/full/v14/i13/2100.htm
DOI: https://dx.doi.org/10.3748/wjg.14.2100